EMD-15221

Single-particle
5.02 Å
EMD-15221
3D View Gallery
Deposition: 20/06/2022
Map released: 02/11/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-15221

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8a7e summary report (pdf.gz) Map-8a7e FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

PAPP-A dimer in complex with its inhibitor STC2 (CASP target)

EMD-15221

Single-particle
5.02 Å
EMD-15221
3D View Gallery
Deposition: 20/06/2022
Map released: 02/11/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: PAPP-A dimer in complex with its endogenous inhibitor STC2 dimer
Fitted models: 8a7e

Deposition Authors: Kobbero SD , Gajhede M , Mirza OA , Boesen T , Oxvig C
Structure of the proteolytic enzyme PAPP-A with the endogenous inhibitor stanniocalcin-2 reveals its inhibitory mechanism.
Kobbero SD , Gajhede M , Mirza OA , Kloverpris S, Kjaer TR , Mikkelsen JH , Boesen T , Oxvig C
(2022) Nat Commun , 13 , 6084 - 6084
PUBMED: 36257932
DOI: doi:10.1038/s41467-022-33698-8
ISSN: 2041-1723
Grant Support: